Iovance Biotherapeutics Inc (IOVA) — Cash Flow-to-Debt Ratio
Iovance Biotherapeutics Inc (IOVA) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of $-78.70 Million could theoretically repay 0% of its total liabilities ($202.66 Million) in one year. See cash generation quality of Iovance Biotherapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Iovance Biotherapeutics Inc Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Iovance Biotherapeutics Inc across 17 annual periods. Also explore IOVA net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Iovance Biotherapeutics Inc (2008–2024)
Year-by-year debt coverage analysis for Iovance Biotherapeutics Inc. For market capitalisation and broader financial context, see Iovance Biotherapeutics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.76x | $-352.98 Million | $200.02 Million | ▲ +4.5% |
| 2023 | -1.85x | $-361.82 Million | $195.74 Million | ▼ -3.8% |
| 2022 | -1.78x | $-292.76 Million | $164.34 Million | ▼ -21.7% |
| 2021 | -1.46x | $-227.94 Million | $155.67 Million | ▲ +20.1% |
| 2020 | -1.83x | $-205.13 Million | $111.96 Million | ▲ +47.3% |
| 2019 | -3.48x | $-158.89 Million | $45.68 Million | ▲ +49.8% |
| 2018 | -6.92x | $-101.25 Million | $14.63 Million | ▲ +13.0% |
| 2017 | -7.96x | $-78.71 Million | $9.89 Million | ▼ -21.0% |
| 2016 | -6.58x | $-32.67 Million | $4.97 Million | ▲ +41.7% |
| 2015 | -11.28x | $-18.38 Million | $1.63 Million | ▼ -117.1% |
| 2014 | -5.20x | $-8.63 Million | $1.66 Million | ▼ -222.0% |
| 2013 | -1.61x | $-3.66 Million | $2.27 Million | ▼ -716.9% |
| 2012 | -0.20x | $-2.24 Million | $11.35 Million | ▲ +57.4% |
| 2011 | -0.46x | $-6.19 Million | $13.35 Million | ▲ +38.5% |
| 2010 | -0.75x | $-620.80K | $822.87K | ▼ -20.7% |
| 2009 | -0.62x | $-14.45K | $23.12K | ▲ +96.4% |
| 2008 | -17.22x | $-57.30K | $3.33K | — |